Thromboembolism Trials in Milan, Italy
Conditions / Thromboembolism / Milan, Italy
Thromboembolism is a medical condition with active clinical research programs worldwide.
10 total trials for this combination
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00329238 | Secondary Prevention of Venous Thrombo Embolism (VTE). | COMPLETED | PHASE3 |
| NCT00486915 | Impact of Left Atrial Appendage Exclusion on Short-Term Clinical Outcomes and Long-Term Stroke Incidence | COMPLETED | NA |
| NCT02913326 | A Clinical Trial Comparing Efficacy and Safety of Dabigatran Etexilate With Warfarin in Patients With Cerebral Venous and Dural Sinus Thrombosis (RE-SPECT CVT) | COMPLETED | PHASE3 |
| NCT04072068 | Study on Impact of Edoxaban Treatment in Cancer Patients With Venous Thromboembolism During Antineoplastic Therapy | COMPLETED | PHASE4 |
| NCT02447081 | Amplatzer™Amulet™ Post-Market Study (Amulet™PMS) | COMPLETED | — |
| NCT00986154 | Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study). | COMPLETED | PHASE3 |
| NCT00353678 | Factor Xa Inhibitor YM150 for the Prevention of Blood Clot Formation in Veins After Scheduled Hip Replacement (ONYX-2) | COMPLETED | PHASE2 |
| NCT00847301 | Pradaxa (Dabigatran Etexilate) 150 mg/q.d. in Patients With Moderate Renal Impairment After Hip or Knee Replacement Surgery | COMPLETED | — |
| NCT02564718 | Rivaroxaban for Treatment in Venous or Arterial Thrombosis in Neonates | COMPLETED | PHASE1/PHASE2 |
| NCT00168818 | Dabigatran Etexilate in Extended Venous Thromboembolism (VTE) Prevention After Hip Replacement Surgery | COMPLETED | PHASE3 |